The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edberg, J. C.
Right arrow Articles by Kimberly, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edberg, J. C.
Right arrow Articles by Kimberly, R. P.

The Journal of Immunology, Vol 143, Issue 5 1642-1649, Copyright © 1989 by American Association of Immunologists


ARTICLES

Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells

JC Edberg, PB Redecha, JE Salmon and RP Kimberly
Hospital for Special Surgery, Cornell University Medical College, New York 10021.

Human Fc gamma RIII (CD16), a low-affinity receptor expressed on several different cell types, has a polymorphism on polymorphonuclear cells (Fc gamma RIIIPMN) identified by the NA1 and NA2 markers. Inasmuch as this polymorphism has functional consequences, an understanding of the structural biology of Fc gamma RIII may provide important insight into receptor function. We analyzed Fc gamma RIIIPMN by SDS-PAGE and found that receptor from individuals allotyped for either NA1 or NA2 contained only one protein after removal of N-linked glycosylations (19 and 21 kDa respectively) whereas receptor from NA1/2 individuals contained both bands. Because some reports indicate that digestion of Fc gamma RIII on NK cells (Fc gamma RIIINK) with N- glycanase also results in two bands on SDS-PAGE, we investigated Fc gamma RIIINK to explore the possibility of a corresponding allelic polymorphism in this receptor. Contrary to expectation, Fc gamma RIIINK from all donors irrespective of their NA allotype contained two bands (20 and 24 kDa) on SDS-PAGE after deglycosylation. In addition, those distinct epitopes on the extracellular domain of Fc gamma RIIIPMN found with mAb B73.1 and CLB gran 11 in association with the NA allotypic differences are expressed (or not expressed) on Fc gamma RIIINK independent of donor NA allotype. Fc gamma RIIIPMN and Fc gamma RIIINK differ at the protein level as they have different m.w. (glycosylated and deglycosylated), different epitopes in the extracellular domain (not attributable to tissue-specific glycosylation), and differential expression of the NA allelic protein polymorphism. Although the membrane anchor of Fc gamma RIIIPMN is a phosphatidylinositol-specific phospholipase C sensitive glycosyl-phosphatidylinositol linkage, Fc gamma RIIINK is insensitive to phosphatidylinositol-specific phospholipase C. However, a form of Fc gamma RIIINK is released from NK cells upon incubation at 37 degrees C. Thus, the basis for the two bands in Fc gamma RIIINK after N-linked deglycosylation is neither coexpression of two molecular isoforms with different membrane anchors nor an identifiable allelic polymorphism in m.w. restricted to Fc gamma RIIINK (p less than 10(-6)). The differences between the two receptors indicate that, independent of cell anchor type, PMN and mononuclear cells must have different molecular isoforms. The allelic variants, different isoforms, alternative anchor mechanisms and release processes provide for an extensive genetic and regulatory diversity in Fc gamma RIII function.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Giustiniani, A. Bensussan, and A. Marie-Cardine
Identification and Characterization of a Transmembrane Isoform of CD160 (CD160-TM), a Unique Activating Receptor Selectively Expressed upon Human NK Cell Activation
J. Immunol., January 1, 2009; 182(1): 63 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Jafarshad, M. H. Dziegiel, R. Lundquist, L. K. Nielsen, S. Singh, and P. L. Druilhe
A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII
J. Immunol., March 1, 2007; 178(5): 3099 - 3106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Sweeney and Y. B. Kim
Identification of a Novel Fc{gamma}RIIIa{alpha}-Associated Molecule That Contains Significant Homology to Porcine Cathelin
J. Immunol., January 15, 2004; 172(2): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
B. H. Rovin, L. Lu, and C. B. Marsh
Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc{gamma} receptor cross-linking: role of IL-1{beta}
J. Leukoc. Biol., March 1, 2001; 69(3): 435 - 439.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. E. Chesla, P. Li, S. Nagarajan, P. Selvaraj, and C. Zhu
The Membrane Anchor Influences Ligand Binding Two-dimensional Kinetic Rates and Three-dimensional Affinity of Fcgamma RIII (CD16)
J. Biol. Chem., March 31, 2000; 275(14): 10235 - 10246.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nagarajan, K. Venkiteswaran, M. Anderson, U. Sayed, C. Zhu, and P. Selvaraj
Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function
Blood, February 1, 2000; 95(3): 1069 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Edberg, J. J. Moon, D. J. Chang, and R. P. Kimberly
Differential Regulation of Human Neutrophil Fcgamma RIIa (CD32) and Fcgamma RIIIb (CD16)-induced Ca2+ Transients
J. Biol. Chem., April 3, 1998; 273(14): 8071 - 8079.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Reinagel, M. Gezen, P. J. Ferguson, S. Kuhn, E. N. Martin, and R. P. Taylor
The Primate Erythrocyte Complement Receptor (CR1) as a Privileged Site: Binding of Immunoglobulin G to Erythrocyte CR1 Does Not Target Erythrocytes for Phagocytosis
Blood, February 1, 1997; 89(3): 1068 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Nagarajan, S. Chesla, L. Cobern, P. Anderson, C. Zhu, and P. Selvaraj
Ligand Binding and Phagocytosis by CD16 (Fc [IMAGE] Receptor III) Isoforms
J. Biol. Chem., October 27, 1995; 270(43): 25762 - 25770.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Edberg, C.-T. Lin, D. Lau, J. C. Unkeless, and R. P. Kimberly
The Ca[IMAGE] Dependence of Human Fc[IMAGE] Receptor-initiated Phagocytosis
J. Biol. Chem., September 22, 1995; 270(38): 22301 - 22307.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Hibbs, P Selvaraj, O Carpen, T. Springer, H Kuster, M. Jouvin, and J. Kinet
Mechanisms for regulating expression of membrane isoforms of Fc gamma RIII (CD16)
Science, December 22, 1989; 246(4937): 1608 - 1611.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.